Inogen Inc  

(Public, NASDAQ:INGN)   Watch this stock  
Find more results for INGN
43.84
-0.99 (-2.21%)
Aug 4 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 43.09 - 44.83
52 week 17.72 - 45.75
Open 44.83
Vol / Avg. 204,301.00/268,521.00
Mkt cap 868.89M
P/E 108.73
Div/yield     -
EPS 0.40
Shares 19.28M
Beta     -
Inst. own 98%
Aug 11, 2015
Q2 2015 Inogen Inc Earnings Call - 4:30PM EDT - Add to calendar
Aug 11, 2015
Q2 2015 Inogen Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 9, 2015
Inogen Inc at William Blair Annual Growth Stock Conference
May 12, 2015
Q1 2015 Inogen Inc Earnings Call
May 12, 2015
Q1 2015 Inogen Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 4.66% 6.07%
Operating margin 7.46% 9.34%
EBITD margin - 20.07%
Return on average assets 4.37% 6.14%
Return on average equity 5.24% 18.99%
Employees 411 -
CDP Score - -

Address

326 Bollay Drive
GOLETA, CA 93117
United States - Map
+1-805-5620500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company offers Inogen One systems, such as Inogen One G3 and G2 that concentrate the air around the patients to offer a single source of supplemental oxygen. The Inogen One G3 and G2 have up to 4.5 and five hours of battery life respectively. The Company's Inogen One G2 is effective for nocturnal use.

Officers and directors

Heath Lukatch Ph.D. Independent Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
Raymond O. Huggenberger President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Alison Bauerlein Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary
Age: 33
Bio & Compensation  - Reuters
Scott Wilkinson Executive Vice President - Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Matthew Scribner Executive Vice President - Operations
Age: 47
Bio & Compensation  - Reuters
Brenton Taylor Executive Vice President - Engineering
Age: 33
Bio & Compensation  - Reuters
Byron Myers Vice President - Marketing
Age: 35
Bio & Compensation  - Reuters
Heather D. Rider Director
Age: 55
Bio & Compensation  - Reuters
Benjamin M. Anderson-Ray Independent Director
Age: 59
Bio & Compensation  - Reuters
Loren L. McFarland Independent Director
Age: 55
Bio & Compensation  - Reuters